Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods
Authors:
- Robert KönigsbergRKRobert Königsberg
- Margit GneistMGMargit Gneist
- Daniela Jahn-KuchDJDaniela Jahn-Kuch
- Georg PfeilerGPGeorg Pfeiler
- Gudrun HagerGHGudrun Hager
- Marcus HudecMHMarcus Hudec
- Christian DittrichCDChristian Dittrich
- Robert ZeillingerRobert Zeillinger
- 1 July 2010
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 293 (1) , 117-123
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapiesBreast Cancer Research and Treatment, 2008
- Isolated Tumor Cells and Circulating CK20 mRNA in pN0 Colorectal Cancer PatientsInternational Journal of Surgical Pathology, 2008
- The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancerAnnals of Oncology, 2007
- Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancerInternational Journal of Cancer, 2005
- Comparison of two methods for enumerating circulating tumor cells in carcinoma patientsCytometry Part B: Clinical Cytometry, 2005
- Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative ActivityClinical Cancer Research, 2005
- Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast CancerJournal of Clinical Oncology, 2005
- Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen‐receptor status and predicts for poor prognosisInternational Journal of Cancer, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Epitope Specificity of 30 Monoclonal Antibodies against Cytokeratin Antigens: The ISOBM TD5-1 WorkshopTumor Biology, 1998